NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
Baylor College of Medicine
Turning Point Therapeutics, Inc.
Washington University School of Medicine
Situs Cancer Research Center
Cedars-Sinai Medical Center
Cyteir Therapeutics, Inc.
Cedars-Sinai Medical Center
Case Comprehensive Cancer Center
Scripps Health
M.D. Anderson Cancer Center
Celgene
Memorial Sloan Kettering Cancer Center
Celldex Therapeutics
AHS Cancer Control Alberta
Rutgers, The State University of New Jersey
The Cleveland Clinic
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Kentucky
National Cancer Institute (NCI)
OHSU Knight Cancer Institute
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Case Comprehensive Cancer Center